Table of Contents

1. Introduction
 1.1 Market Definition & Scope
 1.2 Research Assumptions & Abbreviations
 1.3 Research Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2035
 2.3 Market Size & Forecast, By Segmentation, 2022 – 2035
  2.3.1 Market Size By Type
  2.3.2 Market Size By Application
  2.3.3 Market Size By End User
 2.4 Market Share & Bps Analysis By Region, 2025
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO's Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter's) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1 Medical Device Manufacturers
  3.4.2 Technology & Software Providers
  3.4.3 Rehabilitation Centers, Hospitals, Clinics (End-Users)
  3.4.4 Patients & Caregivers (End Consumers)
 3.5 Industry Life Cycle Assessment
 3.6 Parent Market Overview (Rehabilitation Services & Medical Devices)
 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting
 4.1 Patient Outcome & Treatment Efficacy Metrics
  4.1.1 Overview
  4.1.2 Functional Independence Measure (FIM) Score Improvements by Therapy Type
  4.1.3 Average Therapy Session Frequency & Duration Trends
  4.1.4 Patient Recovery Timeline Analysis by Neurological Condition
  4.1.5 Quality of Life Assessment Score Benchmarking

 4.2 Technology Adoption & Device Utilization Metrics
  4.2.1 Overview
  4.2.2 Robotic-Assisted Therapy Adoption Rate by Facility Type
  4.2.3 Virtual Reality Integration in Rehabilitation Programs
  4.2.4 Wearable Sensor Technology Deployment Trends
  4.2.5 Telerehabilitation Platform Utilization & Patient Engagement

 4.3 Healthcare System & Reimbursement Metrics
  4.3.1 Overview
  4.3.2 Insurance Coverage Rates for Advanced Neurorehabilitation Technologies
  4.3.3 Average Cost per Rehabilitation Episode by Treatment Modality
  4.3.4 Rehabilitation Facility Capacity & Wait Time Analysis
  4.3.5 Cost-Effectiveness Analysis: Traditional vs. Technology-Enabled Therapy

 4.4 Clinical Research & Innovation Metrics
  4.4.1 Overview
  4.4.2 Active Clinical Trial Count by Rehabilitation Technology Category
  4.4.3 Medical Device Regulatory Approval Timeline Trends
  4.4.4 Research Publication Volume & Citation Analysis
  4.4.5 Patent Filing Activity in Neurorehabilitation Technologies

5. Neurorehabilitation Market Segmental Analysis & Forecast, By Type, 2022 – 2035, Value (USD Billion)
 5.1 Introduction
 5.2 Neuro-Robotic Devices
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Non-Invasive Stimulators
 5.4 Brain-Computer Interfaces

6. Neurorehabilitation Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion)
 6.1 Introduction
 6.2 Brain Stroke
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022 – 2035
 6.3 Parkinson's Disease
 6.4 Multiple Sclerosis
 6.5 Spinal Cord Injury
 6.6 Traumatic Brain Injury
 6.7 Cerebral Palsy
 6.8 Others

7. Neurorehabilitation Market Segmental Analysis & Forecast, By End User, 2022 – 2035, Value (USD Billion)
 7.1 Introduction
 7.2 Rehabilitation Centers
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022 – 2035
 7.3 Hospitals
 7.4 Clinics

8. Neurorehabilitation Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)
 8.1 Introduction
 8.2 North America
  8.2.1 Key Trends
  8.2.2 Neurorehabilitation Market Size & Forecast, By Type, 2022 – 2035
  8.2.3 Neurorehabilitation Market Size & Forecast, By Application, 2022 – 2035
  8.2.4 Neurorehabilitation Market Size & Forecast, By End User, 2022 – 2035
  8.2.5 Neurorehabilitation Market Size & Forecast, By Country, 2022 – 2035
   8.2.5.1 USA
   8.2.5.2 Canada

 8.3 Europe
  8.3.1 Key Trends
  8.3.2 Neurorehabilitation Market Size & Forecast, By Type, 2022 – 2035
  8.3.3 Neurorehabilitation Market Size & Forecast, By Application, 2022 – 2035
  8.3.4 Neurorehabilitation Market Size & Forecast, By End User, 2022 – 2035
  8.3.5 Neurorehabilitation Market Size & Forecast, By Country, 2022 – 2035
   8.3.5.1 Germany
   8.3.5.2 UK
   8.3.5.3 France
   8.3.5.4 Italy
   8.3.5.5 Spain
   8.3.5.6 Russia
   8.3.5.7 Poland
   8.3.5.8 Rest of Europe

 8.4 Asia-Pacific
  8.4.1 Key Trends
  8.4.2 Neurorehabilitation Market Size & Forecast, By Type, 2022 – 2035
  8.4.3 Neurorehabilitation Market Size & Forecast, By Application, 2022 – 2035
  8.4.4 Neurorehabilitation Market Size & Forecast, By End User, 2022 – 2035
  8.4.5 Neurorehabilitation Market Size & Forecast, By Country, 2022 – 2035
   8.4.5.1 China
   8.4.5.2 India
   8.4.5.3 Japan
   8.4.5.4 South Korea
   8.4.5.5 Australia
   8.4.5.6 ASEAN Countries
   8.4.5.7 Rest of Asia-Pacific

 8.5 Latin America
  8.5.1 Key Trends
  8.5.2 Neurorehabilitation Market Size & Forecast, By Type, 2022 – 2035
  8.5.3 Neurorehabilitation Market Size & Forecast, By Application, 2022 – 2035
  8.5.4 Neurorehabilitation Market Size & Forecast, By End User, 2022 – 2035
  8.5.5 Neurorehabilitation Market Size & Forecast, By Country, 2022 – 2035
   8.5.5.1 Brazil
   8.5.5.2 Argentina
   8.5.5.3 Mexico
   8.5.5.4 Colombia
   8.5.5.5 Rest of Latin America

 8.6 Middle East & Africa
  8.6.1 Key Trends
  8.6.2 Neurorehabilitation Market Size & Forecast, By Type, 2022 – 2035
  8.6.3 Neurorehabilitation Market Size & Forecast, By Application, 2022 – 2035
  8.6.4 Neurorehabilitation Market Size & Forecast, By End User, 2022 – 2035
  8.6.5 Neurorehabilitation Market Size & Forecast, By Country, 2022 – 2035
   8.6.5.1 UAE
   8.6.5.2 Saudi Arabia
   8.6.5.3 Qatar
   8.6.5.4 Egypt
   8.6.5.5 South Africa
   8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape
 9.1 Key Players' Positioning
 9.2 Competitive Developments
  9.2.1 Key Strategies Adopted (%), By Key Players, 2025
  9.2.2 Year-Wise Strategies & Development, 2021 – 2025
  9.2.3 Number Of Strategies Adopted By Key Players, 2025
 9.3 Market Share Analysis, 2025
 9.4 Product/Service & Application Benchmarking
  9.4.1 Product/Service Specifications & Features By Key Players
  9.4.2 Product/Service Heatmap By Key Players
  9.4.3 Application Heatmap By Key Players
 9.5 Industry Start-Up & Innovation Landscape
 9.6 Key Company Profiles
  9.6.1 Ekso Bionics Holdings, Inc.
   9.6.1.1 Company Overview & Snapshot
   9.6.1.2 Product/Service Portfolio
   9.6.1.3 Key Company Financials
   9.6.1.4 SWOT Analysis
  9.6.2 Hocoma AG (DIH Medical Group)
  9.6.3 Bionik Laboratories Corp.
  9.6.4 Medtronic plc
  9.6.5 Abbott Laboratories
  9.6.6 Boston Scientific Corporation
  9.6.7 ReWalk Robotics Ltd.
  9.6.8 Tyromotion GmbH
  9.6.9 BioxtremE S.L.
  9.6.10 Kinetic Muscles Inc.
  9.6.11 Motek Medical B.V.
  9.6.12 Ectron Ltd.
  9.6.13 Helius Medical Technologies, Inc.
  9.6.14 MindMaze Holding SA
  9.6.15 Neurostyle Pty Ltd.
  9.6.16 Kinestica Limited
  9.6.17 Fourier Intelligence
  9.6.18 Myomo, Inc.
  9.6.19 Neuronetics, Inc.
  9.6.20 BrainQ Technologies Ltd.

10. Analyst Recommendations
 10.1 SNS Insider Opportunity Map
 10.2 Industry Low-Hanging Fruit Assessment
 10.3 Market Entry & Growth Strategy
 10.4 Analyst Viewpoint & Suggestions on Market Growth

11. Assumptions

12. Disclaimer

13. Appendix
 13.1 List Of Tables
 13.2 List Of Figures